SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
DrugmakerSuvenLifeSciencesLtdonFridaysaidithassecuredfourproductpatentsforitsNewChemicalEntities(NCEs)fromfourdifferentcountries.Thecompany
has achieved these product patents from Eurasia, Europe, Israel and Macau. “Suven Life secures four product patents in Eurasia, Europe, Israel and Macau,” said
Suven Life Sciences Ltd in a filing to the Bombay Stock Exchange on December 11, 2015.These patents are valid through 2030, it added. “The granted claims of the
patents include the class of selective 5-HT compounds discovered by Suven,” the company said in a statement. Further, the Suven said these compounds are being
developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease,
Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia. commenting on the development, Suven Life Sciences Ltd,
CEO,VenkatJastisaid,“WeareverypleasedbythegrantofthesepatentstoSuvenforourpipelineofmoleculesinCNSarenathatarebeingdeveloped forcognitive
disorders with high unmet medical need with huge market potential globally.” With these new patents, Suven has a total of 15 granted patents from Eurasia, 18
grantedpatentsfromEurope,8grantedpatentsfromIsraeland5productpatentsfromMacau.
Technical Outlook : Ondailychart,stockhassmallBullishcandlestickwithaboveaveragecandlestick,moreoverstockhasgivencloseaboveDoji’shighwhichwas
placedat252.80level, whichshowsfor upside movement. Apartfrom this, stock has managed tocloseabove its200DayMoving Averagewhich is placed at249.80
level, which shows that stock’s medium to long term trend is up. A momentum indicator RSI reading is at 41.88 level and about to make positive crossover, which
pointoutforpositivebreathinthestock.Sofortradingperspective,onecouldBuyintherangeof253-255fortheTargetof261withtheSLof250.
SUVEN
ONGC
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
14th Dec 2015
Sell in the range of 214-216 for the Target of 209 with the SL of 218
Buy in the range of 253-255 for the Target of 261 with the SL of 250
OilpricesextendedtheirfreefallonFriday,flirtingwith11-yearlows,aftertheInternationalEnergyAgency(IEA)warnedthatglobaloversupplyofcrudecouldworsen
next year.Crude prices have fallen with little restraint since OPECabandoned itsoutputceiling of30million bpd.Led by No.1crude exporterSaudi Arabia andother
big Middle Eastoil producers such asIran and Iraq, the group pumped 31.7million bpd in November. Thatwas more oil than in any month pumped by OPEC since
late 2008. The IEA, which advises developed nations on energy, warned that demand growth was starting to slow. Brent and US crude's West Texas Intermediate
(WTI)futuresfellasmildpre-winterweatherandaplummeting USstockmarketaddedtothetollonoilprices.
Technical Outlook : On daily chart, the stock has formed Bearish Engulfing candlestick with above average volume, which shows accentuated selling pressure.
Moreover, stock has given negative breakout of its strong support of 220 level, which indicates that further downside is expected from the present level. A
momentumindicatorRSIreadingisat29.45levelwithnegativecrossover,andhasbeenreadingwithdownwardfallingtrendline,whichpointoutfornegativebreath
inthestock.Sofortradingperspective,onecouldSellintherangeof214-216fortheTargetof209withtheSLof218.
US stocks closed sharply lower on Friday, with the S&P 500 ending its worst week since August, as plunging crude oil
prices compounded investor nervousness on expectations for the first US interest rate hike in nearly a decade. Oil
dragged down market as a whole, as investors worried whether a weakness in commodities signalled a broader
slowdown. Furthermore, investors were worried about declines in China's yuan and in high-yield debt markets. Asian
equities were trading lower on Monday after a further slump in oil prices weighed on Wall Street on Friday.
Indian shares may open weak again, tracking Asian equities after crude oil fell again, this time setting under USD 36 to a
barrel, and ahead of a crucial Federal Reserve interest rate meeting. In Singapore, the SGX Nifty, a futures index tracking
the Indian market, is trading 50 points, or 0.67 percent, lower to 7,570, indicating a similar open for Indian shares. A
proportionate fall in the Sensex could mean it could test 25,000 in early trade, a level it is only 200 points away from.
SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
Corporate Action:
IDFC Bank Limited; Interest Payment
Result Calendar:
MRGNIND, RRFIN.
14th Dec 2015
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 11/12/2015 532939 RPOWER RELIANCE INFRADEVELOPMENT PRIVATE LIMIT S 28000000 49.50
2 11/12/2015 532939 RPOWER RELIANCE INFRASTRUCTURE LIMITED B 28000000 49.50
3 11/12/2015 523642 PIIND SALIL SINGHAL S 8800000 610.72
4 11/12/2015 524470 SYNCOMF UNIVERSAL GOLDEN FUND B 8500000 4.85
5 11/12/2015 534060 PMCFIN VIPUL VIRENDRAKUMAR PATEL B 2457933 0.65
6 11/12/2015 534060 PMCFIN VIPUL VIRENDRAKUMAR PATEL S 2457931 0.69
7 11/12/2015 517300 GIPCL ICICI LOMBARD GENERAL INSURANCE COMPAN B 1000001 77.00
8 11/12/2015 523642 PIIND INDIA MIDCAP MAURITIUS LIMITED B 1000000 610.00
9 11/12/2015 523642 PIIND STICHTING DEPOSITARY APG EMERGING MARK B 950884 610.00
10 11/12/2015 511523 VEERHEALTH DARPAN DEEPAK SHAH S 917030 3.23
IBREALEST & UNITECH
SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
14th Dec 2015
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity
Broking Pvt Ltd., ou=Research Dept,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2015.12.14 08:57:56 +05'30'

Choice - Morning Tea

  • 1.
    SEBI Certified –Research Analyst www.choiceindia.com Global View India Update Today’s Event/ Stock in News DrugmakerSuvenLifeSciencesLtdonFridaysaidithassecuredfourproductpatentsforitsNewChemicalEntities(NCEs)fromfourdifferentcountries.Thecompany has achieved these product patents from Eurasia, Europe, Israel and Macau. “Suven Life secures four product patents in Eurasia, Europe, Israel and Macau,” said Suven Life Sciences Ltd in a filing to the Bombay Stock Exchange on December 11, 2015.These patents are valid through 2030, it added. “The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven,” the company said in a statement. Further, the Suven said these compounds are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia. commenting on the development, Suven Life Sciences Ltd, CEO,VenkatJastisaid,“WeareverypleasedbythegrantofthesepatentstoSuvenforourpipelineofmoleculesinCNSarenathatarebeingdeveloped forcognitive disorders with high unmet medical need with huge market potential globally.” With these new patents, Suven has a total of 15 granted patents from Eurasia, 18 grantedpatentsfromEurope,8grantedpatentsfromIsraeland5productpatentsfromMacau. Technical Outlook : Ondailychart,stockhassmallBullishcandlestickwithaboveaveragecandlestick,moreoverstockhasgivencloseaboveDoji’shighwhichwas placedat252.80level, whichshowsfor upside movement. Apartfrom this, stock has managed tocloseabove its200DayMoving Averagewhich is placed at249.80 level, which shows that stock’s medium to long term trend is up. A momentum indicator RSI reading is at 41.88 level and about to make positive crossover, which pointoutforpositivebreathinthestock.Sofortradingperspective,onecouldBuyintherangeof253-255fortheTargetof261withtheSLof250. SUVEN ONGC SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website Morning Tea 14th Dec 2015 Sell in the range of 214-216 for the Target of 209 with the SL of 218 Buy in the range of 253-255 for the Target of 261 with the SL of 250 OilpricesextendedtheirfreefallonFriday,flirtingwith11-yearlows,aftertheInternationalEnergyAgency(IEA)warnedthatglobaloversupplyofcrudecouldworsen next year.Crude prices have fallen with little restraint since OPECabandoned itsoutputceiling of30million bpd.Led by No.1crude exporterSaudi Arabia andother big Middle Eastoil producers such asIran and Iraq, the group pumped 31.7million bpd in November. Thatwas more oil than in any month pumped by OPEC since late 2008. The IEA, which advises developed nations on energy, warned that demand growth was starting to slow. Brent and US crude's West Texas Intermediate (WTI)futuresfellasmildpre-winterweatherandaplummeting USstockmarketaddedtothetollonoilprices. Technical Outlook : On daily chart, the stock has formed Bearish Engulfing candlestick with above average volume, which shows accentuated selling pressure. Moreover, stock has given negative breakout of its strong support of 220 level, which indicates that further downside is expected from the present level. A momentumindicatorRSIreadingisat29.45levelwithnegativecrossover,andhasbeenreadingwithdownwardfallingtrendline,whichpointoutfornegativebreath inthestock.Sofortradingperspective,onecouldSellintherangeof214-216fortheTargetof209withtheSLof218. US stocks closed sharply lower on Friday, with the S&P 500 ending its worst week since August, as plunging crude oil prices compounded investor nervousness on expectations for the first US interest rate hike in nearly a decade. Oil dragged down market as a whole, as investors worried whether a weakness in commodities signalled a broader slowdown. Furthermore, investors were worried about declines in China's yuan and in high-yield debt markets. Asian equities were trading lower on Monday after a further slump in oil prices weighed on Wall Street on Friday. Indian shares may open weak again, tracking Asian equities after crude oil fell again, this time setting under USD 36 to a barrel, and ahead of a crucial Federal Reserve interest rate meeting. In Singapore, the SGX Nifty, a futures index tracking the Indian market, is trading 50 points, or 0.67 percent, lower to 7,570, indicating a similar open for Indian shares. A proportionate fall in the Sensex could mean it could test 25,000 in early trade, a level it is only 200 points away from.
  • 2.
    SEBI Certified –Research Analyst www.choiceindia.com Bulk Deal Corporate Action / Result Calendar SEBI Certified – Research Analyst www.choiceindia.com Morning Tea Corporate Action: IDFC Bank Limited; Interest Payment Result Calendar: MRGNIND, RRFIN. 14th Dec 2015 Security in Ban SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price 1 11/12/2015 532939 RPOWER RELIANCE INFRADEVELOPMENT PRIVATE LIMIT S 28000000 49.50 2 11/12/2015 532939 RPOWER RELIANCE INFRASTRUCTURE LIMITED B 28000000 49.50 3 11/12/2015 523642 PIIND SALIL SINGHAL S 8800000 610.72 4 11/12/2015 524470 SYNCOMF UNIVERSAL GOLDEN FUND B 8500000 4.85 5 11/12/2015 534060 PMCFIN VIPUL VIRENDRAKUMAR PATEL B 2457933 0.65 6 11/12/2015 534060 PMCFIN VIPUL VIRENDRAKUMAR PATEL S 2457931 0.69 7 11/12/2015 517300 GIPCL ICICI LOMBARD GENERAL INSURANCE COMPAN B 1000001 77.00 8 11/12/2015 523642 PIIND INDIA MIDCAP MAURITIUS LIMITED B 1000000 610.00 9 11/12/2015 523642 PIIND STICHTING DEPOSITARY APG EMERGING MARK B 950884 610.00 10 11/12/2015 511523 VEERHEALTH DARPAN DEEPAK SHAH S 917030 3.23 IBREALEST & UNITECH
  • 3.
    SEBI Certified –Research Analyst www.choiceindia.com Contact Us www.choiceindia.com www.choiceindia.comcustomercare@choiceindia.com Disclaimer This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee against the loss of your entire investment. POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock / Instrument (s): - No. SEBI Certified – Research Analyst www.choiceindia.com Research Team Mr. Sumeet Bagadia Associate Director Kunal Parmar Research Associate Amit Pathania Research Associate Vikas Chaudhari Research Associate Kapil Shah Research Associate Rajnath Yadav Research Associate Satish Kumar Research Associate Morning Tea 14th Dec 2015 SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website Kunal Parmar Digitally signed by Kunal Parmar DN: cn=Kunal Parmar, o=Choice Equity Broking Pvt Ltd., ou=Research Dept, email=kunal.parmar@choiceindia.com, c=IN Date: 2015.12.14 08:57:56 +05'30'